zarontin

Generic: ethosuximide

Labeler: parke-davis div of pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name zarontin
Generic Name ethosuximide
Labeler parke-davis div of pfizer inc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

ethosuximide 250 mg/1

Manufacturer
Parke-Davis Div of Pfizer Inc

Identifiers & Regulatory

Product NDC 0071-0237
Product ID 0071-0237_b98eee67-87bf-4ee3-b210-9f6190fdeae5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA012380
Listing Expiration 2026-12-31
Marketing Start 2000-09-22

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00710237
Hyphenated Format 0071-0237

Supplemental Identifiers

RxCUI
197682 201737
UPC
0300710237247
UNII
5SEH9X1D1D
NUI
N0000175753 N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zarontin (source: ndc)
Generic Name ethosuximide (source: ndc)
Application Number NDA012380 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (0071-0237-24)
source: ndc

Packages (1)

0071-0237-24 100 CAPSULE in 1 BOTTLE (0071-0237-24)

Ingredients (1)

ethosuximide (250 mg/1)

Linked Drug Pages (1)

Zarontin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b98eee67-87bf-4ee3-b210-9f6190fdeae5", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0300710237247"], "unii": ["5SEH9X1D1D"], "rxcui": ["197682", "201737"], "spl_set_id": ["0e008f33-70a1-4bc6-b3a0-d45214418ab6"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (0071-0237-24)", "package_ndc": "0071-0237-24", "marketing_start_date": "20000922"}], "brand_name": "Zarontin", "product_id": "0071-0237_b98eee67-87bf-4ee3-b210-9f6190fdeae5", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-0237", "generic_name": "Ethosuximide", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zarontin", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/1"}], "application_number": "NDA012380", "marketing_category": "NDA", "marketing_start_date": "20000922", "listing_expiration_date": "20261231"}